Hyperfine (HYPR) Depreciation & Amortization (CF) (2021 - 2026)
Hyperfine (HYPR) posted Depreciation & Amortization (CF) of $274000.0 for Q1 2026, down 2.49% on a QoQ basis from $281000.0 in Q4 2025, and up 19.65% year-over-year from $229000.0 in Q1 2025.
Hyperfine (HYPR) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
Hyperfine's Depreciation & Amortization (CF) history runs 6 years deep, the most recent figure standing at $274000.0 for Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 19.65% year-over-year to $274000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 16.41% YoY) and the FY2025 annual result came in at $1.1 million, up 8.03% from the prior year.
- Depreciation & Amortization (CF) was $274000.0 for Q1 2026 at Hyperfine, down from $281000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $297000.0 in Q3 2025 and bottomed at $229000.0 in Q1 2025.
- A 5-year average of $261294.1 and a median of $261000.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
- Peak annual rise in Depreciation & Amortization (CF) reached 163.54% in 2022, while the deepest fall reached 22.55% in 2022.
- Hyperfine's Depreciation & Amortization (CF) stood at $261000.0 in 2022, then increased by 0.77% to $263000.0 in 2023, then dropped by 11.03% to $234000.0 in 2024, then grew by 20.09% to $281000.0 in 2025, then dropped by 2.49% to $274000.0 in 2026.
- Business Quant data shows HYPR's Depreciation & Amortization (CF) at $274000.0 in Q1 2026, $281000.0 in Q4 2025, and $297000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Hyperfine | 92.81 Mn | 51.53 Mn | 1.98 Mn | 274,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 274,000.00 |
| Mar 31, 2026 | 274,000.00 |
| Dec 31, 2025 | 281,000.00 |
| Dec 31, 2025 | 281,000.00 |
| Sep 30, 2025 | 297,000.00 |
| Sep 30, 2025 | 297,000.00 |
| Jun 30, 2025 | 283,000.00 |
| Jun 30, 2025 | 283,000.00 |
| Mar 31, 2025 | 229,000.00 |
| Mar 31, 2025 | 229,000.00 |
| Dec 31, 2024 | 234,000.00 |
| Dec 31, 2024 | 234,000.00 |
| Sep 30, 2024 | 259,000.00 |
| Sep 30, 2024 | 259,000.00 |
| Jun 30, 2024 | 253,000.00 |
| Jun 30, 2024 | 253,000.00 |
| Mar 31, 2024 | 263,000.00 |
| Mar 31, 2024 | 263,000.00 |
| Dec 31, 2023 | 263,000.00 |
| Dec 31, 2023 | 263,000.00 |